Prof Sarath Ranganathan
Prof Sarath Ranganathan
Professor Sarath Ranganathan is the Group Leader of the Respiratory group at MCRI.
Professor Sarath Ranganathan is the Group Leader of the Respiratory group at MCRI.
Top Publications
- Lycett, K, Lotfalian, M, Wang, Y, Walter, C, Irving, L, Liu, M, Ranganathan, S, Burgner, D, O'Neil, A, Silver, JD, et al. To what extent is air pollution associated with cardiorespiratory hospitalisations across Australia? A whole-of-population ecological study.. Public Health Res Pract 36(2) : 2026 view publication
- Harwood, KH, Bannister, S, Duffull, S, Martinez, A, Ranganathan, S, Shanthikumar, S, Gwee, A. Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis.. Br J Clin Pharmacol 2026 view publication
- Hudson, J, Taylor, N, Coffey, MJ, Pushpakumara, BLDU, Prentice, B, Jaffe, A, Visser, S, Sivam, S, Day, AS, Oliver, M, et al. Is the gut a reservoir of non-tuberculous mycobacteria in people with cystic fibrosis?. J Cyst Fibros 2026 view publication
- Maksimovic, J, Shanthikumar, S, Howitt, G, Dixit, G, Hickey, PF, Anttila, C, Brown, DV, Gubbels, L, Senabouth, A, Amann-Zalcenstein, D, et al. Single-cell profiling of BAL in preschool cystic fibrosis reveals macrophage dysregulation and ivacaftor-modified inflammatory programs in the early life lung.. Mucosal Immunol 19(3) : 100338 2026 view publication
- Coffey, MJ, van Dorst, J, Pushpakumara, BU, Hudson, J, Halim, J, Day, AS, Oliver, M, Ranganathan, S, Wainwright, C, Selvadurai, H, et al. EPS6.06 Proton pump inhibitor exposure and gut microbiome development in early childhood cystic fibrosis: insights from the PEARL-CF Study. Journal of Cystic Fibrosis 25: s51 2026 view publication
Page 1 of 78
Career information
Share //
